You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
SCA is an electrical problem with the heart that triggers a dangerously fast heart rate (ventricular tachycardia) or irregular rhythm (ventricular fibrillation). If not treated immediately, SCA can be fatal. Approximately 95% of people who experience an out-of-hospital cardiac arrest event and are not treated by defibrillation within 10 minutes will die.1
Sudden cardiac arrest is not the same as a heart attack. A heart attack is a “plumbing” problem, caused by blockage(s) in the arteries leading to the heart and killing heart muscle. A heart attack may lead to a sudden cardiac arrest event.
The most effective way to treat SCA is through defibrillation. It involves delivering electrical shock to your heart to restore the normal heartbeat. There are two types of devices that can deliver these electrical shocks: AEDs and ICDs.
An AED is a portable device used by emergency response teams or the general public to shock the heart, giving the heart a chance to restart normal electrical activity and resume beating effectively. However, if defibrillation is delayed by more than 10 minutes, the survival in adults is less than 5%.2
An ICD is a device implanted underneath the skin, usually near the collarbone. One or more wires, called leads, run from the ICD through the veins and into the heart. It continuously monitors the heart rhythm. If it detects an abnormal or fast heart rhythm, low or high energy shocks are sent to reset the heart to a normal rhythm.
ICDs are proven to be 98% effective in treating dangerous ventricular arrhythmias that can lead to sudden cardiac arrest.3,4
Zipes DP, Roberts D, for the Pacemaker-Cardioverter-Defibrillator investigators. Results of the International Study of the Implantable Pacemaker Cardioverter-Defibrillator: A Comparison of Epicardial and Endocardial Lead Systems. Circulation. July 1, 1995;92(1):59-65.
Volosin, et al. Virtual ICD: A Model to Evaluate Shock Reduction Strategies. Presented at HRS 2010 (PO3-125).
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.